Curis (CRIS)
(Delayed Data from NSDQ)
$5.14 USD
-0.11 (-2.10%)
Updated Oct 2, 2024 04:00 PM ET
After-Market: $5.06 -0.08 (-1.56%) 7:58 PM ET
4-Sell of 5 4
F Value C Growth B Momentum D VGM
Curis (CRIS) Price Targets
Average Price Target | Highest Price Target | Lowest Price Target | Upside to Average Price Target |
---|---|---|---|
$26.00 | $26.00 | $26.00 | 405.84% |
Price Target
Based on short-term price targets offered by two analysts, the average price target for Curis comes to $26.00. The forecasts range from a low of $26.00 to a high of $26.00. The average price target represents an increase of 405.84% from the last closing price of $5.14.
Analyst Price Targets (2 )
Broker Rating
Curis currently has an average brokerage recommendation (ABR) of 1.50 on a scale of 1 to 5 (Strong Buy to Strong Sell), calculated based on the actual recommendations (Buy, Hold, Sell etc.) made by four brokerage firms. The current ABR compares to an ABR of 1.50 a month ago based on four recommendations.
Of the four recommendations deriving the current ABR, three are Strong Buy, representing 75% of all recommendations. A month ago, Strong Buy represented 75%.
Broker Rating Breakdown
Brokerage Recommendations
Today | 1 Week Ago | 1 Month Ago | 2 Months Ago | 3 Months Ago | |
---|---|---|---|---|---|
Strong Buy | 3 | 3 | 3 | 3 | 3 |
Buy | 0 | 0 | 0 | 0 | 0 |
Hold | 1 | 1 | 1 | 1 | 1 |
Sell | 0 | 0 | 0 | 0 | 0 |
Strong Sell | 0 | 0 | 0 | 0 | 0 |
ABR | 1.50 | 1.50 | 1.50 | 1.50 | 1.50 |
1. Not Ident. Many of the brokerage firms who provide Zacks data ask that we keep their identity confidential.
2. In most cases the # of brokers listed above is less than the # of brokerage firms that have a recommendation on the stock. That is because some firms prohibit Zacks from displaying detailed information on their recommendations such as in the upgrade/downgrade table.
Analyst Upgrades/Downgrades
Date | Brokerage Firm | Analyst | Previous | Current |
---|---|---|---|---|
9/27/2024 | H.C. Wainwright & Co. | Edward White | Strong Buy | Strong Buy |
8/5/2024 | Truist Securities | Srikripa Devarakonda | Strong Buy | Strong Buy |
8/1/2024 | Not Identified | Not Identified | Hold | Hold |
5/8/2024 | Cantor Fitzgerald & Co | Li Watsek | Strong Buy | Strong Buy |
1. Not Ident. Many of the brokerage firms who provide Zacks data ask that we keep their identity confidential.
2. In most cases the # of brokers listed above is less than the # of brokerage firms that have a recommendation on the stock. That is because some firms prohibit Zacks from displaying detailed information on their recommendations such as in the upgrade/downgrade table.
Average Brokerage Rating
Current ABR | 1.50 |
ABR (Last week) | 1.50 |
# of Recs in ABR | 4 |
Average Target Price | $26.00 |
LT Growth Rate | NA |
Industry | Medical - Biomedical and Genetics |
Industry Rank by ABR | 75 of 252 |
Current Quarter EPS Est: | -1.88 |
CRIS FAQs
Curis, Inc. (CRIS) currently has an average brokerage recommendation (ABR) of 1.50 on a scale of 1 to 5 (Strong Buy to Strong Sell), calculated based on the actual recommendations (Buy, Hold, Sell etc.) made by 4 brokerage firms.
The average price target for Curis, Inc. (CRIS) is $26.00. The current on short-term price targets is based on 4 reports.
The forecasts for Curis, Inc. (CRIS) range from a low of $26 to a high of $26. The average price target represents a increase of $405.84 from the last closing price of $5.14.
The current UPSIDE for Curis, Inc. (CRIS) is 405.84%
Based on short-term price targets offered by two analysts, the average price target for Curis comes to $26.00. The forecasts range from a low of $26.00 to a high of $26.00. The average price target represents an increase of 405.84% from the last closing price of $5.14.